Situation profile

Male infertility: comparing established care with regenerative offers

This is a composite decision situation, not a real patient, testimonial or individual treatment recommendation.

Male infertility: comparing established care with regenerative offers

Abnormal semen results or a failed fertility pathway can make a treatment described as restoring testicular function sound direct and logical. Before comparing prices, identify the diagnosis: obstruction, hormonal causes, genetic factors and impaired sperm production do not share one regenerative pathway.

What the data says for this situation

Registry snapshot (2026-08-29): MSC studies: 4 (1 recruiting) · HSCT-family: 2 · exosomes: 1. Source: ClinicalTrials.gov API v2.

The registry shows limited cell-therapy activity for male infertility. A small footprint cannot establish routine use, and a change in one semen parameter is not automatically the same as pregnancy or live birth. The exact cause and patient-important endpoint matter.

Questions worth asking any provider

  1. What diagnosis is the intervention intended to address?
  2. Was the same product studied for that cause of infertility?
  3. Were pregnancy or live-birth outcomes measured, or only laboratory markers?
  4. Could treatment delay time-sensitive fertility preservation or assisted reproduction?

Red flags specific to this situation

  • One injection offered for every cause of male infertility
  • Claims based only on sperm-count changes without reproductive outcomes
  • No reproductive-urology or fertility specialist involved

Cost context

Compare the complete experimental pathway with diagnostic work-up, fertility preservation and established assisted-reproduction options, including the partner's pathway where relevant.

FAQ

Can stem cells restore male fertility?

It remains investigational and depends on the underlying cause; registry activity is not proof of a live-birth benefit.

Which outcome matters most?

That depends on the goal, but laboratory changes should not be presented as equivalent to pregnancy or live birth.

→ Build questions for a specific provider · → Cost calculator

Interactive/editorial page by the StemCellAtlas research team. Where registry or literature counts appear, they use the dated 2026-08-29 snapshot. Browser-only tools do not send or store answers. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads